Stephen Mackinnon

14.9k citations

239 papers · 12.6k · 2 hit papers · h-index 59

Impact in

Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 0.5%

Papers in

Hematology 145
- Hematopoietic Stem Cell Transplantation 113
- Chronic Myeloid Leukemia Treatments 35
- Acute Myeloid Leukemia Research 24
Immunology 78
- Immune Cell Function and Interaction 43
- T-cell and B-cell Immunology 41

Co-authors: Karl S. Peggs (76 shared papers)Kirsty J. Thomson (49 shared papers)David C. Linch (33 shared papers)Anthony H. Goldstone (28 shared papers)Stephanie Verfuerth (20 shared papers)Farid Boulad (6 shared papers)Hugo R Castro-Malaspina (6 shared papers)Emma C. Morris (31 shared papers)
Journals: Blood (71 papers)British Journal of Haematology (28 papers)Bone Marrow Transplantation (27 papers)Transplantation and Cellular Therapy (16 papers)Journal of Clinical Oncology (7 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

Stephen Mackinnon

236 papers receiving 12.2k citations

Stephen Mackinnon's Hit Papers

align trajectories log scale

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease 1995 · 637 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

1995 Blood
1994 New England Journal of Medicine

Peers

Countries citing papers authored by Stephen Mackinnon

Since Specialization

Citations

This map shows the geographic impact of Stephen Mackinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Mackinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Mackinnon more than expected).

Fields of papers citing papers by Stephen Mackinnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Mackinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Mackinnon. The network helps show where Stephen Mackinnon may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Mackinnon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Mackinnon Line = papers co-authored together Stephen Mackinnon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation New England Journal of Medicine ·Esperanza Bouza Papadopoulos, Marc Ladanyi, David M. Emanuel, Stephen Mackinnon, Farid Boulad, Matthew H. Carabasi, Hugo R Castro-Malaspina, Barrett H. Childs Hit paper breakdown →	1994	889
2	Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood ·Stephen Mackinnon, EB Papadopoulos, MH Carabasi, LILIAN M. REICH, NH Collins, Farid Boulad, Hugo R Castro-Malaspina, BH Childs Hit paper breakdown →	1995	637
3	In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Blood ·Panagiotis D. Kottaridis, Donald William Milligan, Rajesh Kumar Chopra, Ronjon K. Chakraverty, Suparno Chakrabarti, Stephen Paul Robinson, Karl S. Peggs, Stephanie Verfuerth	2000	456
4	Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions Blood ·TN Small, Esperanza Bouza Papadopoulos, Farid Boulad, Patricia M. Black, Hugo R Castro-Malaspina, BH Childs, N H Collins, AP Gillio	1999	422
5	Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines The Lancet ·Karl S. Peggs, Stephanie Verfuerth, Arnold R. Pizzey, Naeem Ahmad Khan, Malcolm Guiver, Paul Moss, Stephen Mackinnon	2003	394
6	High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution Blood ·Suparno Chakrabarti, Stephen Mackinnon, Raj K. Chopra, Panagiotis D. Kottaridis, Karl S. Peggs, Peter O’Gorman, Ronjon K. Chakraverty, Timothy F. Marshall	2002	324
7	Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation Blood ·Stephen Paul Robinson, Anthony H. Goldstone, Stephen Mackinnon, Angelo Michele Carella, Nigel H. Russell, Carmen Ruiz de Elvira, Goli Taghipour, Norbert Schmitz	2002	319
8	Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen Blood ·Ronjon K. Chakraverty, Karl S. Peggs, Rajesh Kumar Chopra, Donald William Milligan, Panagiotis D. Kottaridis, Stephanie Verfuerth, Johanne Geary, Dharsha Thuraisundaram	2002	309
9	Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma Blood ·Emma C. Morris, Kirsty J. Thomson, Charles Craddock, Prem Mahendra, Donald William Milligan, Gordon C Cook, Graeme Smith, Anne N. Parker	2004	244
10	Specific human cellular immunity to bcr-abl oncogene-derived peptides Blood ·Monica Bocchia, Tatyana Korontsvit, Qin Xu, Stephen Mackinnon, Shang‐You Yang, Alessandro Sette, DA Scheinberg	1996	241
11	Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation The Lancet ·Karl S. Peggs, Ann Hunter, Rajesh Kumar Chopra, Anne N. Parker, Premini Mahendra, Donald William Milligan, Charles Craddock, Ruth Pettengell	2005	228
12	Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation Transplantation and Cellular Therapy ·Joseph H. Antin, Richard W. Childs, Alexandra Hult Filipovich, Sergio Giralt, Stephen Mackinnon, Thomas R. Spitzer, Daniel Jordan Weisdorf	2001	220
13	Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders Blood ·José Antonio Pérez‐Simón, Panagiotis D. Kottaridis, Rodrigo Martino, Charles Craddock, Dolores Caballero, Raj K. Chopra, Javier García-Conde, Don W. Milligan	2002	210
14	Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia Journal of Clinical Oncology ·Sudhir Tauro, Charles Craddock, Karl S. Peggs, Gulnaz Begum, Premini Mahendra, Gordon C Cook, Judith Marsh, Donald William Milligan	2005	199
15	Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation Clinical Infectious Diseases ·Karl S. Peggs, Kirsty J. Thomson, Edward R. Samuel, Gemma Dyer, Julie Armoogum, Ronjon K. Chakraverty, K. H. Pang, Stephen Mackinnon	2010	194
16	T-Cell–Depleted Allogeneic Bone Marrow Transplantation as Postremission Therapy for Acute Myelogenous Leukemia: Freedom From Relapse in the Absence of Graft-Versus-Host Disease Blood ·Esperanza Bouza Papadopoulos, Matthew H. Carabasi, Hugo R Castro-Malaspina, Barrett H. Childs, Stephen Mackinnon, Farid Boulad, Alfred P. Gillio, Nancy A. Kernan	1998	184
17	Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications Blood ·Emma C. Morris, Peppy Rebello, Kirsty J. Thomson, Karl S. Peggs, Charalampia Kyriakou, Anthony H. Goldstone, Stephen Mackinnon, G Hale	2003	174
18	Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses Blood ·Karl S. Peggs, Kirsty J. Thomson, Daniel P. Hart, Johanne Geary, Emma C. Morris, Kwee Yong, Anthony H. Goldstone, David C. Linch	2003	171
19	The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation Blood ·Andrea Knight, J. Alejandro Madrigal, Sarah Grace, Janani Sivakumaran, Panagiotis D. Kottaridis, Stephen Mackinnon, Paul J. Travers, Mark W. Lowdell	2010	168
20	Minimal residual disease is more common in patients who have mixed T- cell chimerism after bone marrow transplantation for chronic myelogenous leukemia Blood ·Stephen Mackinnon, Lorna Barnett, Glenn Heller, RJ O’Reilly	1994	152

About Stephen Mackinnon

Stephen Mackinnon is a scholar working on Hematology, Immunology, Genetics, Oncology and Epidemiology, having authored 239 papers that have together received 12.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (113 papers), Cytomegalovirus and herpesvirus research (52 papers), Immune Cell Function and Interaction (43 papers), T-cell and B-cell Immunology (41 papers), Chronic Myeloid Leukemia Treatments (35 papers), Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Acute Myeloid Leukemia Research (24 papers). The work is most often cited by research in Hematology (6.7k citations), Transplantation (580 citations), Immunology (4.5k citations), Oncology (3.9k citations) and Genetics (1.5k citations). Stephen Mackinnon has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Karl S. Peggs, Kirsty J. Thomson, David C. Linch, Anthony H. Goldstone, Stephanie Verfuerth, Farid Boulad, Hugo R Castro-Malaspina, Emma C. Morris, Ronjon K. Chakraverty and Panagiotis D. Kottaridis. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Transplantation and Cellular Therapy and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stephen Mackinnon

Impact in

Papers in i

In The Last Decade

Stephen Mackinnon

Stephen Mackinnon's Hit Papers

Peers

Countries citing papers authored by Stephen Mackinnon

Fields of papers citing papers by Stephen Mackinnon

All Works

About Stephen Mackinnon

Explore authors with similar magnitude of impact

Papers in